A detailed history of L.M. Kohn & Company transactions in Amgen Inc stock. As of the latest transaction made, L.M. Kohn & Company holds 2,174 shares of AMGN stock, worth $686,984. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,174
Previous 2,184 0.46%
Holding current value
$686,984
Previous $620,000 9.52%
% of portfolio
0.19%
Previous 0.18%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$262.75 - $319.31 $2,627 - $3,193
-10 Reduced 0.46%
2,174 $679,000
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $15,056 - $18,175
56 Added 2.63%
2,184 $620,000
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $25,570 - $28,845
100 Added 4.93%
2,128 $612,000
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $214 - $253
-1 Reduced 0.05%
2,028 $450,000
Q1 2023

May 08, 2023

BUY
$225.79 - $275.2 $225 - $275
1 Added 0.05%
2,029 $490,000
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $61,838 - $78,572
270 Added 15.36%
2,028 $532,000
Q3 2022

Oct 19, 2022

SELL
$224.46 - $253.15 $224 - $253
-1 Reduced 0.06%
1,758 $397,000
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $2,307 - $2,567
10 Added 0.57%
1,759 $428,000
Q1 2022

May 25, 2022

BUY
$219.27 - $242.57 $383,503 - $424,254
1,749 New
1,749 $423,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track L.M. Kohn & Company Portfolio

Follow L.M. Kohn & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L.M. Kohn & Company, based on Form 13F filings with the SEC.

News

Stay updated on L.M. Kohn & Company with notifications on news.